Chemotactic peptides - Mechanisms, functions, and possible role in inflammatory bowel disease

Digestive Diseases and Sciences

Volumn 33, Issue 3 Supplement, 1988, Pages

  Nast, Cynthia C ^a,b   LeDuc, Louise E ^a,b  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

chemotaxis; colitis; leukotrienes; peptides

Indexed keywords

LEUKOTRIENE; OXYGEN RADICAL; PEPTIDE;

CHEMOTAXIS; CROHN DISEASE; HUMAN; PRIORITY JOURNAL; REVIEW; ULCERATIVE COLITIS;

ANIMAL; CHEMOTACTIC FACTORS; COLITIS, ULCERATIVE; CROHN DISEASE; HUMAN; INTESTINAL MUCOSA; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023901001     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/BF01538131     Document Type: Article

References (81)

1. Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes
2. Further studies on the chemotactic factor of complement and its formation in vivo
3. Polymorphonuclear leukocyte chemotactic activity in rabbit serum and guinea pig serum treated with immune complexes: Evidence for C5a as the major chemotactic factor
4. Regulation of the polymorphonuclear leukocyte chemotactic response by immunological reactions
5. Complement mediators of inflammation
6. The in vivo effect of leukotriene B4 on polymorphonuclear leukocytes and the microcirculation
7. Polymorphonuclear leukocyte chemotaxis toward oxidized lipid components of cell membranes
8. The isolation and partial characterization of neutrophil chemotactic factors from Escherichia coli
9. N-Formylmethionyl peptides as chemoattractants for leukocytes
10. The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal enzyme secretion for neutrophils
11. Methyl ester of N-formylmethionyl-leucyl-phenylalanine
12. Factors from saliva and oral bacteria chemotactic for polymorphonuclear leukocytes: Their possible role in gingival inflammation
13. Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli
14. Purification and characterization of neutrophil chemotactic factors of Streptococcus sanguis
15. Preformed eosinophil chemotactic factor of anaphylaxis
16. Studies on chemotaxis. V. On the chemotactic effect of bacteria
17. Bacterial factors chemotactic for polymorphonuclear leukocytes
18. Antibiotics and peptides with agonist and antagonist chemotactic activity
19. Structural requirements for synthetic peptide chemoattractants and antagonists
20. Chemotactic peptides as probes of molecular events in leukocyte chemotaxis
21. Chemotactic factor inactivation by myeloperoxidase-mediated oxidation of methionine
22. N-Formylmethionyl-ionyl-sRNA as the initiator of protein synthesis
23. Further studies on the structural requirements for synthetic peptide chemoattractants
24. An eosinophil leukocyte chemotactic factor of anaphylaxis
25. IgE-mediated release of an eosinophil leukocyte chemotactic factor from human lung
26. Inactivation of slow-reacting substance of anaphylaxis by human eosinophil arylsulfatase
27. Chemotactic deactivation of human eosinophils by the eosinophilic chemotactic factor of anaphylaxis
28. Human eosinophils, acidic tetrapeptides (ECF-A) and histamine
29. Structural determinants of the eosinophil chemotactic activity of the acidic tetrapeptides of eosinophil chemotactic factor of anaphylaxis
30. Purification and synthesis of eosinophilic tetrapeptides of human lung tissue: Identification as eosinophil chemotactic factor of anaphylaxis
31. Demonstration of a receptor on rabbit neutrophils for chemotactic peptides
32. Development of specific receptors for N-formylated chemotactic peptides in a human monocyte cell line stimulated with lymphokines
33. Inhibition of in vivo and in vitro neutrophil responses to chemotactic factors by a competitive antagonist
34. 5,8,11,14-Eicosatetraynoic acid (ETYA) inhibits binding of N-formyl-methionyl-leucyl-phenylalanine (FMLP) to its receptor on human granulocytes
35. Removal or oxidation of surface membrane sialic acid inhibits formyl-peptide-induced polymorphonuclear leukocyte chemotaxis
36. Pathophysiologic aspects of leukocyte chemotaxis: Identification of a specific chemotactic factor binding site on human granulocytes and defects of macrophage function associated with neoplasia
37. Activation of neutrophils by N-formyl chemotactic peptides
38. Activation of the human neutrophil secretory process with 5(s), 12 (R)-dihydroxy-6,14- cis-8,10- trans-eicosatetranoic acid
39. The oligopeptide chemotactic factor receptor on human polymorphonuclear leukocyte membranes exists in two affinity states
40. Chemoattractant receptor functions in human polymorphonuclear leukocytes are divergently altered by membrane fluidizers
41. Regulatory mechanisms of a chemoattractant receptor on leukocytes
42. Amphotericin B alters the affinity and functional activity of the oligopeptide chemotactic factor receptor on human polymorphonuclear leukocytes
43. Dynamics of human neutrophil receptors for the chemoattractant f-Met-Leu-Phe
44. Receptor-mediated uptake and degradation of125I-chemotactic peptide by human neutrophils
45. Mobilization and adaptation of human neutrophil chemoattractant f-Met-Leu-Phe receptors
46. Evidence that functional responses of human neutrophils occur independently of transient elevations in cyclic AMP levels
47. Neutrophil stimulation: receptor, membrane, and metabolic events
48. Receptor-mediated activation of a phospholipase A2 in rabbit neutrophil plasma membrane
49. Role of Ca2+ in phosphatidylinositol response and arachidonic acid release in formylated tripeptide or Ca2+ ionophore A23187-stimulated guinea pig neutrophils
50. Direct demonstration of increased intracellular concentration of free calcium in rabbit and human neutrophils following stimulation by chemotactic factor
51. Synthetic chemotactic peptides as initiators of multiple biologic functions of the neutrophil: The role of calcium
52. Generation of superoxide radicals by human peripheral neutrophils activated by chemotactic factor. Evidence for the role of calcium
53. Pertussis toxin inhibits chemotactic factor-induced phospholipase C stimulation and lysomal enzyme secretion in rabbit neutrophils
54. ADP-ribosylation of the specific membrane protein by islet-activating protein, pertussis toxin, associated with inhibition of a chemotactic peptide-induced arachidonate release in neutrophils
55. Phorbol esters inhibit the f-Met-Leu-Phe and leukotriene B4-stimulated calcium mobilization and enzyme secretion in rabbit neutrophils
56. Stimulation of arachidonic acid metabolism in the polymorphonuclear leukocyte by an N-formylated peptide
57. Neutrophil degranulation: Evidence pertaining to its mediation by combined effects of leukotriene B4, platelet-activating factor and 5-HETE
58. Effects of leukotrienes and f-Met-Leu-Phe on oxidative metabolism of neutrophils and eosinophils
59. Stimulation by lipoxygenase products of superoxide anion production in FMLP-treated neutrophils
60. Leukotriene biosynthesis by polymorphonuclear leukocytes from two patients with chronic granulomatous disease
61. Differential effects of lipoxygenase products on FMLP and LTB4 evoked neutrophil aggregation
62. Heterogeneity of human polymorphonuclear leukocyte receptors for leukotriene B4. Identification of a subset of high affinity receptors that transduce the chemotactic response
63. Generation and recognition of leukotriene mediators of hypersensitivity and inflammation
64. Arachidonate metabolism by human polymorphonuclear leukocytes stimulated by N-formyl-Met-Leu-Phe or complement component C5a is independent of phospholipase activation
65. Characterization of effect of N-formyl-methionyl-leucyl-phenylalinine on leukotriene synthesis in human polymorphonuclear leukocytes
66. A novel leukotriene produced by stimulation of leukocytes with formyl-methionyl-leucyl-phenylalanine
67. Leukotriene C4: Isolation from human polymorphonuclear leukocytes
68. Enhancement of human neutrophil adherence by synthetic leukotriene constituents of the slow-reacting substance of anaphylaxis
69. Arachidonic acid induced degranulation of rabbit peritoneal neutrophils
70. Arachidonate metabolite(s) increase the permeability of the plasma membrane of the neutrophils to calcium
71. Targeted modulation of acute inflammation
72. Acute colitis produced by chemotactic peptides in rats and mice
73. Chemotactic peptide stimulation of leukotrienes from healthy and inflamed rabbit colons
74. Sites of eicosanoid production in healthy colons and experimental colitis
75. Intestinal permeability in children with Crohn's disease and coeliac disease
76. Absorption of 51-chromium-labelled ethylenediaminetetracetate in inflammatory bowel disease
77. Abnormal small intestinal permeability to sugars in patients with Crohn's disease of the terminal ilium and colon
78. Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor
79. Composition of human colonic mucin. Selective alteration in inflammatory bowel disease
80. Neutrophil-mediated mucosal injury: Role of reactive oxygen metabolites